Loading stockRelated stocks: Real Estate
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Loading stockRelated stocks: Real Estate
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Real estate company · NV · FY ends May · -1280.06% margin
$0.00
$0.00 (-35.90%)
Price from 2 days ago
The institution is unprofitable. This typically signals severe credit losses or a business in transition.
Revenue declined 25.0% YoY. For a bank, this often signals contracting loan book or reduced fee income.
Financial stocks carry unique risks (credit cycles, regulatory changes, interest rate sensitivity) that aren't captured by standard quality metrics.
9.7x earnings. Below the sector average, the market may be pricing in credit losses or regulatory headwinds, or there's genuine value here.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (FY)
$23K
▼ -25.0% YoY
Net Income (TTM)
$108K
▲ +61.6% YoY
Net Margin
—
P/E
9.7x
Balance Sheet
Total Assets
$456K
Equity
-$2M
Total Debt
$2M
Cash & Equiv.
$75.00
5Y CAGR: -37.9%
Continue Research
SourceComputed from the 10-Q filed 20 Apr 2026, covering the period ending 28 Feb 2026, as reported to the SEC. Data last refreshed 22 Apr 2026. How this is calculated.
Price from market data, last close as of 31 Aug 2026. Fiscal year ends May. Sector medians are approximate S&P 500 benchmarks and update periodically.
At a P/E of 9.7, Cannabis Suisse (CSUI)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Cannabis Suisse scores 15/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Cannabis Suisse scores 15 out of 100 on Intrinsiqq's quality score, a weighted blend of 2 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -1,280.1% operating margin. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh CSUI's valuation and scores 15/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.